Tower Research Capital LLC (Trc) Orchard Therapeutics PLC Transaction History

Tower Research Capital LLC (Trc)

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.36 - $0.49 $3,204 - $4,361	8,901 Added 1182.07%	9,654 $4,000
Q3 2022 Nov 10, 2022	SELL	$0.45 - $0.69 $2,910 - $4,462	-6,467 Reduced 89.57%	753 $0
Q2 2022 Aug 15, 2022	SELL	$0.42 - $0.78 $4,075 - $7,568	-9,703 Reduced 57.34%	7,220 $4,000
Q1 2022 May 12, 2022	SELL	$0.7 - $1.51 $15,883 - $34,263	-22,691 Reduced 57.28%	16,923 $12,000
Q4 2021 Feb 14, 2022	BUY	$1.16 - $2.23 $25,790 - $49,579	22,233 Added 127.92%	39,614 $53,000
Q3 2021 Nov 15, 2021	BUY	$2.24 - $4.29 $33,192 - $63,569	14,818 Added 578.15%	17,381 $40,000
Q2 2021 Aug 16, 2021	SELL	$4.39 - $7.23 $8,354 - $13,758	-1,903 Reduced 42.61%	2,563 $11,000
Q1 2021 May 17, 2021	BUY	$4.39 - $9.08 $908 - $1,879	207 Added 4.86%	4,466 $32,000
Q4 2020 Feb 16, 2021	BUY	$3.86 - $5.07 $9,414 - $12,365	2,439 Added 134.01%	4,259 $18,000
Q3 2020 Nov 16, 2020	SELL	$4.11 - $6.45 $1,915 - $3,005	-466 Reduced 20.38%	1,820 $7,000
Q2 2020 Aug 13, 2020	BUY	$5.75 - $11.99 $13,144 - $27,409	2,286 New	2,286 $14,000
Q3 2019 Nov 05, 2019	SELL	$11.88 - $16.72 $17,665 - $24,862	-1,487 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$13.2 - $20.63 $19,628 - $30,676	1,487 New	1,487 $21,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.